Correspondence to the Editor: “Use of Intravenous Fat Emulsions in Adult Critically Ill Patients: Does omega 3 make a difference?”

  • Norbert Nagel B. Braun Melsungen AG
  • Anna Harder B. Braun Melsungen AG

Abstract

With great interest we have read your recent publication on “Use of Intravenous Fat Emulsions in Adult Critically Ill Patients: Does omega 3 make a difference?” by Donoghue et al. South African Journal of Clinical Nutrition. 2017;30(3): 38-48.

Author Biographies

Norbert Nagel, B. Braun Melsungen AG
Senior Scientific Manager Medical Scientific Affairs Hospital Care B. Braun Melsungen AG
Anna Harder, B. Braun Melsungen AG
Product Manager Single Nutrients Global Marketing and Sales B. Braun Melsungen AG
Published
2018-04-06
How to Cite
Nagel, N., & Harder, A. (2018). Correspondence to the Editor: “Use of Intravenous Fat Emulsions in Adult Critically Ill Patients: Does omega 3 make a difference?”. South African Journal of Clinical Nutrition, 31(1), 26-27. Retrieved from http://sajcn.redbricklibrary.com/index.php/SAJCN/article/view/1312
Issue
Vol 31 No 1 (2018)
Section
Letters to the Editor
Material submitted for publication in the South African Journal of Clinical Nutrition (SAJCN) is accepted provided it has not been published elsewhere. Copyright forms will be sent with acknowledgement of receipt and the SAJCN reserves copyright of the material published.

The SAJCN does not hold itself responsible for statements made by the authors.